Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ technology to make permanent alterations to the human genome, aiming to cure diseases and advance genome engineering.
Notice Date
January 6, 2026
—
March 8, 2026
Permanent
Layoff
Remote
Connecticut
